Curing Agent Market by Curing Agent Type (Anhydride, Isocyanate, Phenolic), Application (Adhesives, Castings, Coatings), End Use Industry, Form - Global Forecast 2025-2032
Description
The Curing Agent Market was valued at USD 8.52 billion in 2024 and is projected to grow to USD 8.87 billion in 2025, with a CAGR of 5.60%, reaching USD 13.19 billion by 2032.
Strategic overview of curing agent functions, industrial significance, and intersecting regulatory and sustainability forces that shape formulation choices
Curing agents play a pivotal role in polymer chemistry by initiating crosslinking reactions that transform reactive resins into durable, functional materials. Their influence extends across formulations used in adhesives, coatings, composites, electronics, and castings, where they dictate cure kinetics, thermal and chemical resistance, and long-term performance. As industries demand higher performance from structural adhesives and high-temperature composites, curing agents increasingly become the design lever that balances processability with end-use properties.
Moreover, material selection now intersects with broad industrial trends: sustainability mandates, tighter regulatory frameworks on hazardous constituents, and the shift to electrified vehicles and lightweight structures. These forces prompt formulators and buyers to reevaluate legacy chemistries and pursue alternatives that provide equivalent or enhanced performance while aligning with environmental and safety goals. Consequently, research and development efforts have intensified around specialty curing systems, catalysts, and hybrid approaches that can meet complex multi-attribute specifications.
Given these dynamics, stakeholders across the value chain-raw material suppliers, formulators, OEMs, and end users-face strategic choices that affect sourcing, innovation pathways, and competitive positioning. Understanding the chemical, regulatory, and application drivers is essential for designing resilient product roadmaps and maintaining cost-effective, compliant manufacturing operations.
How innovations in chemistry, sustainability mandates, and supply chain resilience are collectively redefining performance requirements and commercial strategies
The curing agent landscape is undergoing transformative shifts driven by innovation in chemistry, value-chain reconfiguration, and evolving end-user expectations. New polymer matrices and composites demand curing systems that deliver faster cures, lower VOCs, and improved thermal stability, which has accelerated work on advanced anhydrides, tailored isocyanates, and novel polyamine systems. At the same time, formulators increasingly prioritize cure performance under constrained process windows, prompting interest in catalysts and latent curing concepts that provide on-demand reactivity.
Concurrently, sustainability and regulatory pressures are reshaping material selection. Stakeholders are turning to bio-based precursors and reduced-toxicity alternatives while investing in closed-loop manufacturing and solvent-free processes. Supply chain resilience has also become a defining priority: the interplay of raw material concentration, logistical bottlenecks, and trade policies has motivated manufacturers to diversify supplier bases and localize critical supply streams. In addition, the electrification of transportation and growth in advanced electronics have elevated demand for specialized curing systems capable of meeting stringent electrical, thermal, and mechanical requirements.
As a result, technology adoption and strategic sourcing decisions increasingly coexist. Companies that integrate material innovation with adaptive supply strategies and targeted collaborations with OEMs and research institutions will capture the operational and competitive advantages emerging from this new landscape.
Assessment of 2025 tariff-driven supply chain reconfiguration and procurement adaptations that influenced sourcing, inventory, and supplier collaboration
The cumulative impact of tariff adjustments implemented in 2025 reverberates across procurement, formulation costs, and supplier strategies within the curing agent ecosystem. Tariff shifts have influenced where manufacturers source intermediates, how they structure contracts, and the calculus around holding strategic inventories. In practical terms, purchasing teams have had to reassess long-standing relationships with overseas suppliers and weigh the merits of nearshoring or regional sourcing to mitigate exposure to variable trade costs.
Moreover, the tariffs prompted greater emphasis on cost transparency and contract flexibility, enabling buyers to pass through or absorb incremental costs according to competitive positioning and margin objectives. For specialty chemistries where substitution is technically complex, buyers focused on collaborative cost-management initiatives with suppliers, such as consignment stocking, dual-sourcing arrangements, and co-development of lower-cost feedstocks.
Looking ahead, many organizations are embedding tariff sensitivity into scenario planning and procurement policies, aligning inventory strategies with production priorities and prioritizing supplier partners that offer technical support alongside supply security. These adaptations have preserved operational continuity while supporting the iterative innovation required to meet end-use specifications.
In-depth segmentation intelligence linking chemical subclasses, application-specific demands, end-use industry constraints, and physical form factors to strategic formulation choices
Segmentation analysis reveals distinct technical and commercial implications based on curing agent type, application, end-use industry, and form. Based on curing agent type, the market is studied across Anhydride, Isocyanate, Phenolic, and Polyamine; the Anhydride category is further examined through methylhexahydrophthalic anhydride, nadic methyl anhydride, and phthalic anhydride, while isocyanates are analyzed via MDI and TDI, phenolics via novolac and resole, and polyamines via aliphatic amine, aromatic amine, and cycloaliphatic amine. Each chemical subclass interacts differently with resin systems, influencing cure speed, pot life, thermal and chemical resistance, and handling safety, which in turn shapes formulation pathways.
Based on application, the market is studied across adhesives, castings, coatings, composites, and electronics, each with its own performance and processing constraints; adhesives require controlled bond strength and adhesion versatility, castings demand dimensional stability and flow characteristics, coatings emphasize cure uniformity and surface properties, composites prioritize interfacial strength and cure control, and electronics necessitate minimal ionic contamination and thermal management. Based on end-use industry, the market is studied across aerospace, automotive, construction, electrical and electronics, and marine, where regulatory drivers, operating environments, and lifecycle expectations influence material choices and acceptance processes. Finally, based on form, the market is studied across liquid, powder, and solid formats, which affect logistics, shelf life, and in-plant handling practices.
Together, these segmentation lenses guide product development, quality-control protocols, and go-to-market strategies, requiring cross-functional alignment between R&D, procurement, and commercial teams to meet sector-specific requirements.
Comparative regional analysis of demand drivers, regulatory pressures, and supply-chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics shape demand profiles, supply-chain configurations, and regulatory compliance strategies in materially different ways. In the Americas, domestic manufacturing strength and proximity to large automotive, aerospace, and electronics OEMs drive demand for high-performance curing systems and enable close supplier–customer collaboration on product qualification and aftermarket support. Regulatory frameworks and chemical management programs in the region also influence the adoption curve for reduced-toxicity and low-emission solutions.
In Europe, Middle East & Africa, regulatory rigor and sustainability initiatives strongly influence product development priorities, especially in sectors such as construction and automotive that face stringent environmental standards. The region’s dense network of specialty chemical producers supports innovation, while market participants navigate a complex patchwork of national regulations and trade considerations. Cultural preferences for localized sourcing and circularity also affect procurement strategies.
In Asia-Pacific, fast-paced industrial growth, expanding electronics manufacturing, and large-scale automotive and marine production underpin robust demand for diverse curing chemistries. The region’s scale and varied regulatory environments encourage a mix of global and regional suppliers, with cost competitiveness and rapid formulation cycles as key differentiators. Across all regions, differences in logistics, feedstock availability, and regulatory enforcement create both challenges and opportunities that require tailored market approaches and localized partnerships.
Competitive dynamics and strategic behaviors among global and regional players that determine technological differentiation, supply reliability, and commercial advantage
Competitive dynamics in the curing agent space reflect a mix of global specialty chemical leaders, regional formulators, and niche innovators that offer differentiated chemistries or service models. Market leaders concentrate on investing in application-driven R&D, expanding technical service capabilities, and securing multi-source raw material supply chains to support reliability for critical end users. At the same time, regional players leverage proximity to local manufacturers and a deeper understanding of domestic regulatory environments to win qualification programs and rapid-turn projects.
Strategic moves commonly include establishing collaborative partnerships with OEMs and formulators, building pilot-scale facilities for customer trials, and deploying targeted sustainability initiatives such as low-emission product lines and bio-based feedstock programs. Additionally, contract manufacturing and toll-blending arrangements enable companies to scale while managing capital intensity and permitting constraints. Intellectual property around curing chemistries, catalysts, and application protocols serves as a competitive moat, and those who combine strong technical advisory services with consistent supply performance secure long-term customer relationships.
In this environment, agility in product customization, regulatory responsiveness, and integrated customer support determine competitive advantage, and companies that align commercial strategy with deep technical capability will more effectively capture differentiated opportunities.
Practical strategic and operational initiatives that companies can implement to strengthen resilience, accelerate sustainable innovation, and deepen customer partnerships
Industry leaders can take several actionable steps to convert insight into market advantage and mitigate operational risk. First, prioritize diversification of critical feedstock sources while cultivating regional supplier relationships to reduce exposure to geopolitical and tariff-related disruptions. This should be complemented by scenario-based inventory strategies that align with production-critical SKUs and qualification timelines. Second, accelerate investment in reduced-toxicity and low-VOC curing solutions through joint development agreements with customers and academic partners, thereby shortening time-to-adoption in regulated markets.
Third, strengthen technical service offerings by embedding application laboratories and pilot-scale validation capabilities near key customers, which will facilitate faster troubleshooting and co-innovation. Fourth, incorporate sustainability metrics and life-cycle considerations into product roadmaps, including circularity initiatives and compatibility with reclaimed or bio-derived feedstocks. Fifth, modernize commercial operations by deploying digital tools for order visibility, predictive inventory planning, and customer-specific formulation libraries that improve responsiveness and lower downtime risk.
Finally, cultivate a talent pipeline with cross-disciplinary expertise in polymer chemistry, regulatory affairs, and supply-chain analytics. Together, these actions will enhance resilience, accelerate commercialization of advanced curing chemistries, and reinforce long-term partnerships with OEMs and formulators.
Comprehensive multi-method research approach integrating primary interviews, technical validation, supply-chain mapping, and scenario stress-testing for reliable insights
The research methodology combines primary and secondary techniques to ensure robust, validated insights across technical and commercial dimensions. Primary research included structured interviews with formulation chemists, procurement leads, quality and regulatory specialists, and end-user engineers to capture real-world performance constraints and purchasing priorities. These discussions were supplemented by validation workshops that reconciled divergent perspectives and prioritized areas of commercial relevance.
Secondary research encompassed peer-reviewed literature, industry standards, patent filings, and technical datasheets to map chemical properties, application suitability, and emerging process technologies. In addition, supply-chain mapping exercises identified key feedstock routes, manufacturing footprints, and logistical considerations. Data triangulation occurred by cross-referencing primary feedback with publicly available regulatory documents and technical performance benchmarks, while quality checks ensured internal consistency and traceability of assumptions.
Finally, scenario analysis and sensitivity testing were used to stress-test conclusions against potential trade, regulatory, and feedstock supply disruptions. This multi-method approach balanced technical rigor with commercial applicability and ensured that conclusions and recommendations reflect both laboratory realities and operational constraints.
Synthesis of technical imperatives, sustainability priorities, and supply-chain strategies that executives must adopt to secure competitive advantage in curing agents
In conclusion, curing agents remain a central determinant of product performance across adhesives, coatings, composites, castings, and electronics. The industry sits at the intersection of advancing material science, heightened sustainability expectations, and shifting trade dynamics, which together demand integrated strategies that combine formulation innovation with robust supply-chain management. Organizations that proactively align R&D, procurement, and customer engagement will be better positioned to deliver differentiated materials that satisfy increasingly complex performance and regulatory requirements.
Moreover, the ability to pivot toward lower-toxicity chemistries, incorporate bio-based feedstocks where feasible, and shorten development cycles through closer collaboration with OEMs will determine winners in high-value segments. Equally important is the adoption of procurement and manufacturing practices that mitigate tariff and logistical risk without compromising technical fidelity. Taken together, these priorities form a coherent action agenda for stakeholders seeking to preserve competitiveness while advancing toward more sustainable, reliable, and high-performance material solutions.
Note: PDF & Excel + Online Access - 1 Year
Strategic overview of curing agent functions, industrial significance, and intersecting regulatory and sustainability forces that shape formulation choices
Curing agents play a pivotal role in polymer chemistry by initiating crosslinking reactions that transform reactive resins into durable, functional materials. Their influence extends across formulations used in adhesives, coatings, composites, electronics, and castings, where they dictate cure kinetics, thermal and chemical resistance, and long-term performance. As industries demand higher performance from structural adhesives and high-temperature composites, curing agents increasingly become the design lever that balances processability with end-use properties.
Moreover, material selection now intersects with broad industrial trends: sustainability mandates, tighter regulatory frameworks on hazardous constituents, and the shift to electrified vehicles and lightweight structures. These forces prompt formulators and buyers to reevaluate legacy chemistries and pursue alternatives that provide equivalent or enhanced performance while aligning with environmental and safety goals. Consequently, research and development efforts have intensified around specialty curing systems, catalysts, and hybrid approaches that can meet complex multi-attribute specifications.
Given these dynamics, stakeholders across the value chain-raw material suppliers, formulators, OEMs, and end users-face strategic choices that affect sourcing, innovation pathways, and competitive positioning. Understanding the chemical, regulatory, and application drivers is essential for designing resilient product roadmaps and maintaining cost-effective, compliant manufacturing operations.
How innovations in chemistry, sustainability mandates, and supply chain resilience are collectively redefining performance requirements and commercial strategies
The curing agent landscape is undergoing transformative shifts driven by innovation in chemistry, value-chain reconfiguration, and evolving end-user expectations. New polymer matrices and composites demand curing systems that deliver faster cures, lower VOCs, and improved thermal stability, which has accelerated work on advanced anhydrides, tailored isocyanates, and novel polyamine systems. At the same time, formulators increasingly prioritize cure performance under constrained process windows, prompting interest in catalysts and latent curing concepts that provide on-demand reactivity.
Concurrently, sustainability and regulatory pressures are reshaping material selection. Stakeholders are turning to bio-based precursors and reduced-toxicity alternatives while investing in closed-loop manufacturing and solvent-free processes. Supply chain resilience has also become a defining priority: the interplay of raw material concentration, logistical bottlenecks, and trade policies has motivated manufacturers to diversify supplier bases and localize critical supply streams. In addition, the electrification of transportation and growth in advanced electronics have elevated demand for specialized curing systems capable of meeting stringent electrical, thermal, and mechanical requirements.
As a result, technology adoption and strategic sourcing decisions increasingly coexist. Companies that integrate material innovation with adaptive supply strategies and targeted collaborations with OEMs and research institutions will capture the operational and competitive advantages emerging from this new landscape.
Assessment of 2025 tariff-driven supply chain reconfiguration and procurement adaptations that influenced sourcing, inventory, and supplier collaboration
The cumulative impact of tariff adjustments implemented in 2025 reverberates across procurement, formulation costs, and supplier strategies within the curing agent ecosystem. Tariff shifts have influenced where manufacturers source intermediates, how they structure contracts, and the calculus around holding strategic inventories. In practical terms, purchasing teams have had to reassess long-standing relationships with overseas suppliers and weigh the merits of nearshoring or regional sourcing to mitigate exposure to variable trade costs.
Moreover, the tariffs prompted greater emphasis on cost transparency and contract flexibility, enabling buyers to pass through or absorb incremental costs according to competitive positioning and margin objectives. For specialty chemistries where substitution is technically complex, buyers focused on collaborative cost-management initiatives with suppliers, such as consignment stocking, dual-sourcing arrangements, and co-development of lower-cost feedstocks.
Looking ahead, many organizations are embedding tariff sensitivity into scenario planning and procurement policies, aligning inventory strategies with production priorities and prioritizing supplier partners that offer technical support alongside supply security. These adaptations have preserved operational continuity while supporting the iterative innovation required to meet end-use specifications.
In-depth segmentation intelligence linking chemical subclasses, application-specific demands, end-use industry constraints, and physical form factors to strategic formulation choices
Segmentation analysis reveals distinct technical and commercial implications based on curing agent type, application, end-use industry, and form. Based on curing agent type, the market is studied across Anhydride, Isocyanate, Phenolic, and Polyamine; the Anhydride category is further examined through methylhexahydrophthalic anhydride, nadic methyl anhydride, and phthalic anhydride, while isocyanates are analyzed via MDI and TDI, phenolics via novolac and resole, and polyamines via aliphatic amine, aromatic amine, and cycloaliphatic amine. Each chemical subclass interacts differently with resin systems, influencing cure speed, pot life, thermal and chemical resistance, and handling safety, which in turn shapes formulation pathways.
Based on application, the market is studied across adhesives, castings, coatings, composites, and electronics, each with its own performance and processing constraints; adhesives require controlled bond strength and adhesion versatility, castings demand dimensional stability and flow characteristics, coatings emphasize cure uniformity and surface properties, composites prioritize interfacial strength and cure control, and electronics necessitate minimal ionic contamination and thermal management. Based on end-use industry, the market is studied across aerospace, automotive, construction, electrical and electronics, and marine, where regulatory drivers, operating environments, and lifecycle expectations influence material choices and acceptance processes. Finally, based on form, the market is studied across liquid, powder, and solid formats, which affect logistics, shelf life, and in-plant handling practices.
Together, these segmentation lenses guide product development, quality-control protocols, and go-to-market strategies, requiring cross-functional alignment between R&D, procurement, and commercial teams to meet sector-specific requirements.
Comparative regional analysis of demand drivers, regulatory pressures, and supply-chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics shape demand profiles, supply-chain configurations, and regulatory compliance strategies in materially different ways. In the Americas, domestic manufacturing strength and proximity to large automotive, aerospace, and electronics OEMs drive demand for high-performance curing systems and enable close supplier–customer collaboration on product qualification and aftermarket support. Regulatory frameworks and chemical management programs in the region also influence the adoption curve for reduced-toxicity and low-emission solutions.
In Europe, Middle East & Africa, regulatory rigor and sustainability initiatives strongly influence product development priorities, especially in sectors such as construction and automotive that face stringent environmental standards. The region’s dense network of specialty chemical producers supports innovation, while market participants navigate a complex patchwork of national regulations and trade considerations. Cultural preferences for localized sourcing and circularity also affect procurement strategies.
In Asia-Pacific, fast-paced industrial growth, expanding electronics manufacturing, and large-scale automotive and marine production underpin robust demand for diverse curing chemistries. The region’s scale and varied regulatory environments encourage a mix of global and regional suppliers, with cost competitiveness and rapid formulation cycles as key differentiators. Across all regions, differences in logistics, feedstock availability, and regulatory enforcement create both challenges and opportunities that require tailored market approaches and localized partnerships.
Competitive dynamics and strategic behaviors among global and regional players that determine technological differentiation, supply reliability, and commercial advantage
Competitive dynamics in the curing agent space reflect a mix of global specialty chemical leaders, regional formulators, and niche innovators that offer differentiated chemistries or service models. Market leaders concentrate on investing in application-driven R&D, expanding technical service capabilities, and securing multi-source raw material supply chains to support reliability for critical end users. At the same time, regional players leverage proximity to local manufacturers and a deeper understanding of domestic regulatory environments to win qualification programs and rapid-turn projects.
Strategic moves commonly include establishing collaborative partnerships with OEMs and formulators, building pilot-scale facilities for customer trials, and deploying targeted sustainability initiatives such as low-emission product lines and bio-based feedstock programs. Additionally, contract manufacturing and toll-blending arrangements enable companies to scale while managing capital intensity and permitting constraints. Intellectual property around curing chemistries, catalysts, and application protocols serves as a competitive moat, and those who combine strong technical advisory services with consistent supply performance secure long-term customer relationships.
In this environment, agility in product customization, regulatory responsiveness, and integrated customer support determine competitive advantage, and companies that align commercial strategy with deep technical capability will more effectively capture differentiated opportunities.
Practical strategic and operational initiatives that companies can implement to strengthen resilience, accelerate sustainable innovation, and deepen customer partnerships
Industry leaders can take several actionable steps to convert insight into market advantage and mitigate operational risk. First, prioritize diversification of critical feedstock sources while cultivating regional supplier relationships to reduce exposure to geopolitical and tariff-related disruptions. This should be complemented by scenario-based inventory strategies that align with production-critical SKUs and qualification timelines. Second, accelerate investment in reduced-toxicity and low-VOC curing solutions through joint development agreements with customers and academic partners, thereby shortening time-to-adoption in regulated markets.
Third, strengthen technical service offerings by embedding application laboratories and pilot-scale validation capabilities near key customers, which will facilitate faster troubleshooting and co-innovation. Fourth, incorporate sustainability metrics and life-cycle considerations into product roadmaps, including circularity initiatives and compatibility with reclaimed or bio-derived feedstocks. Fifth, modernize commercial operations by deploying digital tools for order visibility, predictive inventory planning, and customer-specific formulation libraries that improve responsiveness and lower downtime risk.
Finally, cultivate a talent pipeline with cross-disciplinary expertise in polymer chemistry, regulatory affairs, and supply-chain analytics. Together, these actions will enhance resilience, accelerate commercialization of advanced curing chemistries, and reinforce long-term partnerships with OEMs and formulators.
Comprehensive multi-method research approach integrating primary interviews, technical validation, supply-chain mapping, and scenario stress-testing for reliable insights
The research methodology combines primary and secondary techniques to ensure robust, validated insights across technical and commercial dimensions. Primary research included structured interviews with formulation chemists, procurement leads, quality and regulatory specialists, and end-user engineers to capture real-world performance constraints and purchasing priorities. These discussions were supplemented by validation workshops that reconciled divergent perspectives and prioritized areas of commercial relevance.
Secondary research encompassed peer-reviewed literature, industry standards, patent filings, and technical datasheets to map chemical properties, application suitability, and emerging process technologies. In addition, supply-chain mapping exercises identified key feedstock routes, manufacturing footprints, and logistical considerations. Data triangulation occurred by cross-referencing primary feedback with publicly available regulatory documents and technical performance benchmarks, while quality checks ensured internal consistency and traceability of assumptions.
Finally, scenario analysis and sensitivity testing were used to stress-test conclusions against potential trade, regulatory, and feedstock supply disruptions. This multi-method approach balanced technical rigor with commercial applicability and ensured that conclusions and recommendations reflect both laboratory realities and operational constraints.
Synthesis of technical imperatives, sustainability priorities, and supply-chain strategies that executives must adopt to secure competitive advantage in curing agents
In conclusion, curing agents remain a central determinant of product performance across adhesives, coatings, composites, castings, and electronics. The industry sits at the intersection of advancing material science, heightened sustainability expectations, and shifting trade dynamics, which together demand integrated strategies that combine formulation innovation with robust supply-chain management. Organizations that proactively align R&D, procurement, and customer engagement will be better positioned to deliver differentiated materials that satisfy increasingly complex performance and regulatory requirements.
Moreover, the ability to pivot toward lower-toxicity chemistries, incorporate bio-based feedstocks where feasible, and shorten development cycles through closer collaboration with OEMs will determine winners in high-value segments. Equally important is the adoption of procurement and manufacturing practices that mitigate tariff and logistical risk without compromising technical fidelity. Taken together, these priorities form a coherent action agenda for stakeholders seeking to preserve competitiveness while advancing toward more sustainable, reliable, and high-performance material solutions.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
199 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Development of bio-based polyamine curing agents to meet sustainability targets
- 5.2. Advancements in low-VOC epoxy curing agents for environmentally friendly coatings
- 5.3. Integration of nanoclay and graphene additives in curing agent formulations for enhanced performance
- 5.4. Emergence of UV-LED rapid curing agents in industrial adhesives and coatings applications
- 5.5. Innovation in waterborne curing agent systems for high-performance protective coatings
- 5.6. Customization of curing agent blends for lightweight composite materials in automotive manufacturing
- 5.7. Regulatory-driven reformulation of curing agents to comply with REACH and TSCA requirements
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Curing Agent Market, by Curing Agent Type
- 8.1. Anhydride
- 8.1.1. Methylhexahydrophthalic Anhydride
- 8.1.2. Nadic Methyl Anhydride
- 8.1.3. Phthalic Anhydride
- 8.2. Isocyanate
- 8.2.1. MDI
- 8.2.2. TDI
- 8.3. Phenolic
- 8.3.1. Novolac
- 8.3.2. Resole
- 8.4. Polyamine
- 8.4.1. Aliphatic Amine
- 8.4.2. Aromatic Amine
- 8.4.3. Cycloaliphatic Amine
- 9. Curing Agent Market, by Application
- 9.1. Adhesives
- 9.2. Castings
- 9.3. Coatings
- 9.4. Composites
- 9.5. Electronics
- 10. Curing Agent Market, by End Use Industry
- 10.1. Aerospace
- 10.2. Automotive
- 10.3. Construction
- 10.4. Electrical And Electronics
- 10.5. Marine
- 11. Curing Agent Market, by Form
- 11.1. Liquid
- 11.2. Powder
- 11.3. Solid
- 12. Curing Agent Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Curing Agent Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Curing Agent Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Aditya Birla Group
- 15.3.2. Air Products and Chemicals Inc
- 15.3.3. Akzo Nobel N.V.
- 15.3.4. Albemarle Corporation
- 15.3.5. Allnex Belgium SA
- 15.3.6. Arkema SA
- 15.3.7. Ashland Global Holdings Inc
- 15.3.8. Atul Ltd
- 15.3.9. BASF SE
- 15.3.10. Cardolite Corporation
- 15.3.11. Covestro AG
- 15.3.12. DIC Corporation
- 15.3.13. Dow Inc
- 15.3.14. Evonik Industries AG
- 15.3.15. Gabriel Performance Products
- 15.3.16. Hexion Inc
- 15.3.17. Huntsman Corporation
- 15.3.18. Incorez Ltd
- 15.3.19. Kukdo Chemical Co Ltd
- 15.3.20. LANXESS AG
- 15.3.21. Mitsubishi Chemical Corporation
- 15.3.22. Momentive Performance Materials Inc
- 15.3.23. Olin Corporation
- 15.3.24. Reichhold LLC
- 15.3.25. Wanhua Chemical Group Co Ltd
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
